Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
International Journal of Clinical Oncology|January 30, 2026
Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective studyYoshitaka Kaido, Masahiro Kagabu, Yohei Chiba, et al.International Journal of Clinical Oncology|May 26, 2019
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)Hiroyuki Fujiwara, Kimio Ushijima, Shoji Nagao, et al.International Journal of Clinical Oncology|January 20, 2016
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit StudyMasahiro Kagabu, Tadahiro Shoji, Kazuyuki Murakami, et al.Journal of Gynecologic Oncology|February 13, 2026
Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter studyHemian Zhang, Masayuki Futagami, Rie Miura, et al.International Journal of Clinical Oncology|October 10, 2022
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.Cancers|November 27, 2024
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.Gynecologic Oncology|April 29, 2022
Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)Terumi Tanigawa, Nobuhiro Takeshima, Hideki Ishikawa, et al.International Journal of Clinical Oncology|July 18, 2014
Evaluation of postoperative chemotherapy in patients with uterine carcinosarcoma: a retrospective survey of the Tohoku Gynecologic Cancer UnitAi Otsuki, Takeo Otsuki, Hideki Tokunaga, et al.International Journal of Clinical Oncology|February 25, 2015
Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer UnitMasayuki Futagami, Yoshihito Yokoyama, Kaori Iino, et al.International Journal of Clinical Oncology|February 12, 2017
Current Status of Uterine Leiomyosarcoma in the Tohoku Region: Results of the Tohoku Translational Center Development Network SurveyHideki Tokunaga, Fumiaki Takahashi, Hiroki Yamamoto, et al.Pageof 9